Four more foreign insurance companieshave been given approval to open branchesor set up joint ventures in China by theInsurance Regulatory Commission.They
On September 28, the National Development and Reform Commission (NDRC) revealed on its official website that in August-September this year, it approved 2 copper exploitation pro-
The Ministry of Commerce of China(MOC)said on April 24th it had approved JapanbasedMitsubishi Rayon Co.’s acquisition ofU.K.based Lucite International Group withconditions.Mitsubishi Rayon on December 22nd,2008 appli...The Ministry of Commerce of China(MOC)said on April 24th it had approved JapanbasedMitsubishi Rayon Co.’s acquisition ofU.K.based Lucite International Group withconditions.Mitsubishi Rayon on December 22nd,2008 applied to MOC for approval of itsacquisition proposal of Lucite. After reviewingthe proposal, the MOC said the deal wouldharm normal competition in China’s methylmethacrylate(MMA)market.展开更多
Chinese National Development and Reform Commission (NDRC) has approved the Tianjinpetrochemical jv complex currently under construction in Tianjin between China Petroleum &Chemical Corporation (Sinopec Corp.) and ...Chinese National Development and Reform Commission (NDRC) has approved the Tianjinpetrochemical jv complex currently under construction in Tianjin between China Petroleum &Chemical Corporation (Sinopec Corp.) and Saudi Basic Industries Corporation (SABIC).SABIC announced July 1 lth.展开更多
The Ministry of Environmental Protection(MOEP)approved on March 23rd seven organizationsto supply testing services for newchemical substances registration.The namesheet includes the Biological and Safety DetectingLabo...The Ministry of Environmental Protection(MOEP)approved on March 23rd seven organizationsto supply testing services for newchemical substances registration.The namesheet includes the Biological and Safety DetectingLaboratory of Shanghai Academy ofPublic Measurement,the Pesticide EnvironmentalAssessment and Pollution Control KeyLaboratory of MOEP Nanjing Research Instituteof Environmental Sciences,the ToxiSafeAssessment Centre of Shenyang ResearchInstitute of Chemical Industry(also called theChemical Industry Pesticide Safety Assessmentand Quality Supervision & CheckCenter),the Environmental Check展开更多
On November 9th, the National Developmentand Reform Commission of China (NDRC)announced that it has recently approved the450 t/d recycling alkali project of ShangdongHuatai Paper Co., Ltd. (SHPC) as the cleandevelopme...On November 9th, the National Developmentand Reform Commission of China (NDRC)announced that it has recently approved the450 t/d recycling alkali project of ShangdongHuatai Paper Co., Ltd. (SHPC) as the cleandevelopment mechanism project. Swiss CarbonAlliance is SHPC’s foreign partner on thisproject, which aimed at reducing 44 392 tonsof carbon dioxide emission every year. Inaddition, another cooperation project展开更多
China’s State Council has approved in principle afive-year environmental protection program thatsets out guidelines,major tasksand measures forthe government to tackle pollution.The program has put"pollution con...China’s State Council has approved in principle afive-year environmental protection program thatsets out guidelines,major tasksand measures forthe government to tackle pollution.The program has put"pollution control and pre-vention"as its focus with the aim of achieving展开更多
On August 14th the National Development and Reform Commission approved the 300000 tons crude oil terminal project to be constructed on the Xianren Island harbor of
Historically,"big pharma"did most central nervous system drug discovery R&D in-house.Yet,in modern times their"management reductionism"resulted in disappointing pipelines and pharma resided to(...Historically,"big pharma"did most central nervous system drug discovery R&D in-house.Yet,in modern times their"management reductionism"resulted in disappointing pipelines and pharma resided to(late)development,regulatory approval,and marketing(Thong,2015).This had significant consequences for financing and executing research,resulting in a larger role for funding by governments and patient-organizations and a shift of research to academia(Mazzucato,2013).展开更多
State Administration for Market Regulation and National Standardization Administration of China have approved the following 278 voluntary national standards and 3 voluntary national standards with amendment.
Objective To put forward some suggestions for improving the registration and regulation,the efficiency of evaluation,and approval of biosimilar in China so as to promote the development of biopharmaceutical industry a...Objective To put forward some suggestions for improving the registration and regulation,the efficiency of evaluation,and approval of biosimilar in China so as to promote the development of biopharmaceutical industry and increase the accessibility of therapeutic drugs in China.Methods Literature related to the registration and regulation,evaluation and approval of biosimilars were sorted out to analyze the differences in China and the USA.Results and Conclusion Based on the analysis of the current situation of registration and regulation of biosimilars between China and the USA,it is suggested to improve the registration and regulation of biosimilars in China from the following four aspects:Establishing a biosimilar regulatory department,expanding the professional evaluation personnel,scientifically simplifying the registration and approval procedures,and constantly refining the types of communication meetings.展开更多
State Administration for Market Regulation and National Standardization Administration of China have approved the following 416 voluntary national standards and 3 voluntary national standards with amendment.
To the Editor:Immune checkpoint inhibitors(ICIs)interact with critical factors involved in immunoregulation.Following the FDA approval of nivolumab as a second line therapy for unresectable hepatocellular carcinoma(HC...To the Editor:Immune checkpoint inhibitors(ICIs)interact with critical factors involved in immunoregulation.Following the FDA approval of nivolumab as a second line therapy for unresectable hepatocellular carcinoma(HCC)in 2017,numerous HCC patients have experienced benefits from ICIs[1].In 2020,the FDA approved the combination of atezolizumab and bevacizumab as first line treatment for unresectable HCCs that have not undergone prior systemic treatments[2].ICIs are driving a transformative change in the field of cancer therapy.展开更多
Ethical approval is the first essential step for medical master’s students to officially initiate research.This article discusses the ethical issues encountered in various types of research projects conducted by prof...Ethical approval is the first essential step for medical master’s students to officially initiate research.This article discusses the ethical issues encountered in various types of research projects conducted by professional master’s students,the preparation of ethical application materials,conflicts between the timing of ethical applications and the clinical training rotation schedules,and the continuity of ethical applications among students within the same cohort and across different cohorts.展开更多
State Administration for Market Regulation and National Standardization Administration of China have approved the following 10 national standards and 1 national standard with amendment.
State Administration for Market Regulation and National Standardization Administration of China have approved the following 12 national standards and 3 national standards with amendment.
文摘Four more foreign insurance companieshave been given approval to open branchesor set up joint ventures in China by theInsurance Regulatory Commission.They
文摘On September 28, the National Development and Reform Commission (NDRC) revealed on its official website that in August-September this year, it approved 2 copper exploitation pro-
文摘The Ministry of Commerce of China(MOC)said on April 24th it had approved JapanbasedMitsubishi Rayon Co.’s acquisition ofU.K.based Lucite International Group withconditions.Mitsubishi Rayon on December 22nd,2008 applied to MOC for approval of itsacquisition proposal of Lucite. After reviewingthe proposal, the MOC said the deal wouldharm normal competition in China’s methylmethacrylate(MMA)market.
文摘Chinese National Development and Reform Commission (NDRC) has approved the Tianjinpetrochemical jv complex currently under construction in Tianjin between China Petroleum &Chemical Corporation (Sinopec Corp.) and Saudi Basic Industries Corporation (SABIC).SABIC announced July 1 lth.
文摘The Ministry of Environmental Protection(MOEP)approved on March 23rd seven organizationsto supply testing services for newchemical substances registration.The namesheet includes the Biological and Safety DetectingLaboratory of Shanghai Academy ofPublic Measurement,the Pesticide EnvironmentalAssessment and Pollution Control KeyLaboratory of MOEP Nanjing Research Instituteof Environmental Sciences,the ToxiSafeAssessment Centre of Shenyang ResearchInstitute of Chemical Industry(also called theChemical Industry Pesticide Safety Assessmentand Quality Supervision & CheckCenter),the Environmental Check
文摘On November 9th, the National Developmentand Reform Commission of China (NDRC)announced that it has recently approved the450 t/d recycling alkali project of ShangdongHuatai Paper Co., Ltd. (SHPC) as the cleandevelopment mechanism project. Swiss CarbonAlliance is SHPC’s foreign partner on thisproject, which aimed at reducing 44 392 tonsof carbon dioxide emission every year. Inaddition, another cooperation project
文摘China’s State Council has approved in principle afive-year environmental protection program thatsets out guidelines,major tasksand measures forthe government to tackle pollution.The program has put"pollution control and pre-vention"as its focus with the aim of achieving
文摘On August 14th the National Development and Reform Commission approved the 300000 tons crude oil terminal project to be constructed on the Xianren Island harbor of
基金funded by the FWO(1S34321N)the Fondation Charcot Stichting(to TV and RS)。
文摘Historically,"big pharma"did most central nervous system drug discovery R&D in-house.Yet,in modern times their"management reductionism"resulted in disappointing pipelines and pharma resided to(late)development,regulatory approval,and marketing(Thong,2015).This had significant consequences for financing and executing research,resulting in a larger role for funding by governments and patient-organizations and a shift of research to academia(Mazzucato,2013).
文摘State Administration for Market Regulation and National Standardization Administration of China have approved the following 278 voluntary national standards and 3 voluntary national standards with amendment.
文摘Objective To put forward some suggestions for improving the registration and regulation,the efficiency of evaluation,and approval of biosimilar in China so as to promote the development of biopharmaceutical industry and increase the accessibility of therapeutic drugs in China.Methods Literature related to the registration and regulation,evaluation and approval of biosimilars were sorted out to analyze the differences in China and the USA.Results and Conclusion Based on the analysis of the current situation of registration and regulation of biosimilars between China and the USA,it is suggested to improve the registration and regulation of biosimilars in China from the following four aspects:Establishing a biosimilar regulatory department,expanding the professional evaluation personnel,scientifically simplifying the registration and approval procedures,and constantly refining the types of communication meetings.
文摘State Administration for Market Regulation and National Standardization Administration of China have approved the following 416 voluntary national standards and 3 voluntary national standards with amendment.
文摘To the Editor:Immune checkpoint inhibitors(ICIs)interact with critical factors involved in immunoregulation.Following the FDA approval of nivolumab as a second line therapy for unresectable hepatocellular carcinoma(HCC)in 2017,numerous HCC patients have experienced benefits from ICIs[1].In 2020,the FDA approved the combination of atezolizumab and bevacizumab as first line treatment for unresectable HCCs that have not undergone prior systemic treatments[2].ICIs are driving a transformative change in the field of cancer therapy.
文摘Ethical approval is the first essential step for medical master’s students to officially initiate research.This article discusses the ethical issues encountered in various types of research projects conducted by professional master’s students,the preparation of ethical application materials,conflicts between the timing of ethical applications and the clinical training rotation schedules,and the continuity of ethical applications among students within the same cohort and across different cohorts.
文摘State Administration for Market Regulation and National Standardization Administration of China have approved the following 10 national standards and 1 national standard with amendment.
文摘State Administration for Market Regulation and National Standardization Administration of China have approved the following 12 national standards and 3 national standards with amendment.
